A/Prof Mark Yates

Experts / A/Prof Mark Yates

A/Prof Mark Yates

Director of Clinical Studies, Ballarat Clinical School at Deakin University

Associate Prof Mark Yates is a consultant physician in geriatric medicine. He has clinical roles in the Grampians Region Cognitive Dementia and Memory Service (CDAMS) and as a Geriatrician to the Ballarat Health Services Sub-Acute Service.

Dementia & chronic disease – Practical advice

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

Neurology

Podcasts

Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2

When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient's health

Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2

When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient's health

By A/Prof Mark Yates

Podcasts

Neurology

Dementia & chronic disease – Practical advice

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

By A/Prof Mark Yates

Podcasts

Geriatric medicine

A/Prof Mark Yates

Director of Clinical Studies, Ballarat Clinical School at Deakin University

More from this expert

Dementia & chronic disease – Practical advice

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2

When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient's health

Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2

When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient's health

Dementia & chronic disease – Practical advice

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Tuesday 17th March, 7pm - 9pm AEDT

Speakers

Dr Charlotte Hespe & Dr Ramy Bishay

General Practitioner & Endocrinologist

Join Dr Charlotte Hespe and Dr Ramy Bishay for this expert panel webcast presentation, where they will discuss the role of GLP-1 in the management of CKD in T2D.

A/Prof Mark Yates

Director of Clinical Studies, Ballarat Clinical School at Deakin University

More from this expert

Dementia & chronic disease – Practical advice

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2

When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient's health

Mild cognitive impairment – Sharing the diagnosis and following up with your patient: Part 2

When seeing a patient with mild cognitive impairment it is critical for us to know that we are in control, and that we can achieve many positives for the patient's health

Dementia & chronic disease – Practical advice

A/Prof Mark Yates describes the interaction between dementia and comorbidities.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Tuesday 17th March, 7pm - 9pm AEDT

Speakers

Dr Charlotte Hespe & Dr Ramy Bishay

General Practitioner & Endocrinologist

Join Dr Charlotte Hespe and Dr Ramy Bishay for this expert panel webcast presentation, where they will discuss the role of GLP-1 in the management of CKD in T2D.